Psychedelic-Assisted Psychotherapy Education at GSPP: Assessing PsyD Student and Alumni Interest, Attitudes, and Perceived Training Needs
Devon Seelig
July 16, 2026 DOI: 10.56902/etdcrp.2026.20 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Exploratory survey |
|---|---|
| Population | Current students and alumni of the Graduate School of Professional Psychology’s PsyD program at the University of Denver |
| Topics | Psychedelic-assisted therapy |
| Keywords | Coursework Accreditation Training meteorology Professional development Higher education Exploratory research Graduate students Occupational training Medical education |
| Key findings | Substantial interest in greater exposure to PAP-related education exists among students and alumni, alongside a perceived gap between the expansion of psychedelic medicine and current formal training. |
Abstract
Interest in psychedelic-assisted psychotherapy (PAP) is expanding rapidly within research, policy reform, and clinical application. Despite this rapid growth, formal training in PAP within accredited doctoral psychology programs is limited to nonexistent. This doctoral project aimed to assess interest in and attitudes toward PAP-related education among current students and alumni of the Graduate School of Professional Psychology’s PsyD program at the University of Denver. An exploratory survey was created to assess interest, likelihood of engagement, perceived benefits and concerns regarding coursework or training opportunities. Findings revealed substantial interest in greater exposure to PAP-related education, in addition to thoughtful concerns. Results highlighted a perceived gap between the expansion of psychedelic medicine and the current level of formal training available within GSPP. Although this project does not advocate specific or immediate curricular changes, it provides program-specific data to inform internal discussions on potential future training directions. These findings may contribute to broader conversations about graduate-level competency development in PAP.
Comparable studies
Other cross-sectional and survey studies on psychedelic-assisted therapy, most cited first.
Citations in the library
Cites 39
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine October 1, 2023
- Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology March 1, 2015
and 34 more in the library